Difficulty: Medium
Average Score: 83%
Practice
A 30-year-old man who has had focal epilepsy for 15 years still experiences four to five episodes per month despite medication. He takes two anticonvulsants; his current medications are the ninth and tenth drugs he has tried. Repeated EEGs have shown a right temporal focus. He is on disability and lives with his parents. What is the next best step in management of this patient?
Correct answer
C
Rationale
In the case presented, the next best step in managing the patient is option C: surgical evaluation. This choice is based on the patient's long history of focal epilepsy, multiple failed medication trials, persistent seizures, and identification of a specific focus on EEG.
Surgical evaluation is indicated when a patient's seizures are refractory to medications and when there is a clear seizure focus that can be surgically resected, as in this case. Surgery offers the potential for seizure control or even cure in patients with drug-resistant focal epilepsy.
Option A (addition of a third antiepileptic drug) may not be as effective given the patient's history of trying multiple medications without success. Adding more drugs may increase the risk of side effects without improving seizure control.
Option B (substitution of a new drug) is also less likely to be successful since the patient has already tried multiple medications without adequate seizure control.
Option D (transcranial magnetic stimulation) is not typically indicated in cases of drug-resistant focal epilepsy with a clear seizure focus on EEG. It is more commonly used for other neurological conditions.
Educationally, this case highlights the importance of considering surgical evaluation in patients with drug-resistant focal epilepsy, particularly when there is a clear seizure focus identified on EEG despite multiple medication trials. It also emphasizes the need for a multidisciplinary approach involving neurologists, neurosurgeons, and epileptologists in the management of complex cases like this.
Surgical evaluation is indicated when a patient's seizures are refractory to medications and when there is a clear seizure focus that can be surgically resected, as in this case. Surgery offers the potential for seizure control or even cure in patients with drug-resistant focal epilepsy.
Option A (addition of a third antiepileptic drug) may not be as effective given the patient's history of trying multiple medications without success. Adding more drugs may increase the risk of side effects without improving seizure control.
Option B (substitution of a new drug) is also less likely to be successful since the patient has already tried multiple medications without adequate seizure control.
Option D (transcranial magnetic stimulation) is not typically indicated in cases of drug-resistant focal epilepsy with a clear seizure focus on EEG. It is more commonly used for other neurological conditions.
Educationally, this case highlights the importance of considering surgical evaluation in patients with drug-resistant focal epilepsy, particularly when there is a clear seizure focus identified on EEG despite multiple medication trials. It also emphasizes the need for a multidisciplinary approach involving neurologists, neurosurgeons, and epileptologists in the management of complex cases like this.